Adriane Schilling
Amicus Therapeutics (United States)(US)
Publications by Year
Research Areas
Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Carbohydrate Chemistry and Synthesis, Monoclonal and Polyclonal Antibodies Research, Hormonal and reproductive studies
Most-Cited Works
- → The pharmacological chaperone 1‐deoxygalactonojirimycin increases α‐galactosidase A levels in Fabry patient cell lines(2009)169 cited
- → The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β‐glucosidase(2010)158 cited
- → Co-administration With the Pharmacological Chaperone AT1001 Increases Recombinant Human α-Galactosidase A Tissue Uptake and Improves Substrate Reduction in Fabry Mice(2012)93 cited
- → Improved efficacy of a next-generation ERT in murine Pompe disease(2019)82 cited
- → Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists(2006)46 cited
- → Coformulation of a Novel Human α -Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice(2015)36 cited
- → Small molecule antagonists of the bradykinin B1 receptor(1999)29 cited
- → Combinatorial gene expression using multiple episomal vectors(2000)21 cited
- → Mutagenesis Studies of the Human Erythropoietin Receptor(1997)17 cited
- Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.(1988)